Swissmedic Approves Pfizer/ BioNTech Vaccine for Children Over 5
Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
The Cabinet Committee on Economic Affairs (CCEA) on Wednesday gave approval for committed price support of ₹17,408.85 crore to the Cotton Corporation…
Synopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
The European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…
Pune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…